American Society of Hematology

Fig. 5.

$Fig. 5. Sequential anti-SIVmac239–neutralization antibody titers in rhesus macaques. / Animals were infected with SIV only (A); with SIV followed by a 28-day course of PMPA chemotherapy (B); with SIV, PMPA chemotherapy, and infusions with autologous unfractionated PBMCs (C); with SIV, PMPA chemotherapy, and infusions with anti-CD3/CD28-stimulated and -expanded autologous CD4+ T cells (D).$

Sequential anti-SIVmac239–neutralization antibody titers in rhesus macaques.

Animals were infected with SIV only (A); with SIV followed by a 28-day course of PMPA chemotherapy (B); with SIV, PMPA chemotherapy, and infusions with autologous unfractionated PBMCs (C); with SIV, PMPA chemotherapy, and infusions with anti-CD3/CD28-stimulated and -expanded autologous CD4⁺ T cells (D).

This Feature Is Available To Subscribers Only